Benzinga | Jul 28, 2020 05:43AM EDT

Canaccord Genuity Initiates Coverage On Marrone Bio Innovations with Buy Rating, Announces Price Target of $1.8

Canaccord Genuity analyst Bobby Burleson initiates coverage on Marrone Bio Innovations (NASDAQ:MBII) with a Buy rating and announces Price Target of $1.8.